A Consumer's Guide to Subgroup Analyses

The extent to which a clinician should believe and act on the results of subgroup analyses of data from randomized trials or meta-analyses is controversial. Guidelines are provided in this paper for making these decisions. The strength of inference regarding a proposed difference in treatment effect among subgroups is dependent on the magnitude of the difference, the statistical significance of the difference, whether the hypothesis preceded or followed the analysis, whether the subgroup analysis was one of a small number of hypotheses tested, whether the difference was suggested by comparisons within or between studies, the consistency of the difference, and the existence of indirect evidence that supports the difference. Application of these guidelines will assist clinicians in making decisions regarding whether to base a treatment decision on overall results or on the results of a subgroup analysis.

[1]  K. Bailey,et al.  Inter-study differences: how should they influence the interpretation and analysis of results? , 1987, Statistics in medicine.

[2]  G. Guyatt,et al.  To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis. , 1990, The American journal of medicine.

[3]  R. A. Johnson,et al.  Heart failure in outpatients: a randomized trial of digoxin versus placebo. , 1982, The New England journal of medicine.

[4]  R Peto,et al.  Why do we need some large, simple randomized trials? , 1984, Statistics in medicine.

[5]  J. van Eys,et al.  Interaction between prognostic factors and treatment. , 1983, Controlled clinical trials.

[6]  P. Meier,et al.  Choosing covariates in the analysis of clinical trials. , 1989, Controlled clinical trials.

[7]  D. Tate,et al.  New challenges for thrombolytic therapy. , 1989, Annals of internal medicine.

[8]  M. Buyse,et al.  Analysis of clinical trial outcomes: some comments on subgroup analyses. , 1989, Controlled clinical trials.

[9]  T C Chalmers,et al.  A method for assessing the quality of a randomized control trial. , 1981, Controlled clinical trials.

[10]  D. Sackett.  Clinical diagnosis and the clinical laboratory. , 1978, Clinical and investigative medicine. Medecine clinique et experimentale.

[11]  D. Cook,et al.  Stress ulcer prophylaxis in the critically ill: a meta-analysis. , 1991, The American journal of medicine.

[12]  R. Horwitz,et al.  Complexity and contradiction in clinical trial research. , 1987, The American journal of medicine.

[13]  C. Furberg,et al.  Lessons from overviews of cardiovascular trials. , 1987, Statistics in medicine.

[14]  C. E. Davis,et al.  Empirical Bayes estimates of subgroup effects in clinical trials. , 1990, Controlled clinical trials.

[15]  K. Hirosawa,et al.  Clinical and Echocardiographic Features of Pulmonary Valve Endocarditis , 1983, Circulation.

[16]  J. Wittes,et al.  Evaluating effects of treatment in subgroups of patients within a clinical trial: the case of non-Q-wave myocardial infarction and beta blockers. , 1990, The American journal of cardiology.

[17]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[18]  R Peto,et al.  Why do we need systematic overviews of randomized trials? , 1987, Statistics in medicine.

[19]  J. Fraser,et al.  TREATMENT OF EARLY BREAST CANCER , 1978, The Lancet.

[20]  L Goldman,et al.  Anticoagulants and myocardial infarction. The problems of pooling, drowning, and floating. , 1979, Annals of internal medicine.

[21]  S. Pocock,et al.  Statistical problems in the reporting of clinical trials. A survey of three medical journals. , 1987, The New England journal of medicine.

[22]  A. Oxman,et al.  Effectiveness of Haemophilus influenzae type b vaccines. , 1990, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[23]  D P Byar,et al.  Assessing apparent treatment--covariate interactions in randomized clinical trials. , 1985, Statistics in medicine.

[24]  A Donner,et al.  A Bayesian approach to the interpretation of subgroup results in clinical trials. , 1982, Journal of chronic diseases.

[25]  G. Guyatt,et al.  A controlled trial of digoxin in congestive heart failure. , 1988, The American journal of cardiology.

[26]  B. Schneider.  Analysis of clinical trial outcomes: alternative approaches to subgroup analysis. , 1989, Controlled clinical trials.